Epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) in Sweden 2000–2003, increasing incidence and regional differences by Stenhem, Mikael et al.
BioMed  Central
Page 1 of 7
(page number not for citation purposes)
BMC Infectious Diseases
Open Access Research article
Epidemiology of methicillin-resistant Staphylococcus aureus 
(MRSA) in Sweden 2000–2003, increasing incidence and regional 
differences
Mikael Stenhem*1,2, Åke Örtqvist3, Håkan Ringberg4, Leif Larsson5, 
Barbro Olsson-Liljequist6, Sara Hæggman6, Karl Ekdahl2,7 and The Swedish 
Study Group on MRSA Epidemiology
Address: 1Department of epidemiology, Swedish Institute for Infectious Disease Control, Karolinska Institutet, Solna, Sweden, 2Department of 
Medical Epidemiology and Biostatistics, Karolinska Institutet, Solna, Sweden, 3County Medical Officer for Communicable Disease Control, 
Stockholm County, Stockholm, Sweden, 4Deputy County Medical Officer for Communicable Disease Control, Skåne County, Malmö, Sweden, 
5Department of Hospital Hygiene, Sahlgrenska University Hospital, Göteborg, Sweden, 6Department of bacteriology, Swedish Institute for 
Infectious Disease Control, Solna, Sweden and 7European Centre for Disease Prevention and Control (ECDC), Solna, Sweden
Email: Mikael Stenhem* - mikael.stenhem@smi.ki.se; Åke Örtqvist - ake.ortqvist@sll.se; Håkan Ringberg - Hakan.Ringberg@skane.se; 
Leif Larsson - leif.larsson@vgregion.se; Barbro Olsson-Liljequist - barbro.liljequist@smi.ki.se; Sara Hæggman - Sara.Haeggman@smi.ki.se; 
Karl Ekdahl - karl.ekdahl@ecdc.eu.int; The Swedish Study Group on MRSA Epidemiology - mikael.stenhem@smi.ki.se
* Corresponding author    
Abstract
Background: The occurrence of methicillin-resistant Staphylococcus aureus (MRSA) has gradually
become more frequent in most countries of the world. Sweden has remained one of few
exceptions to the high occurrence of MRSA in many other countries. During the late 1990s,
Sweden experienced a large health-care associated outbreak which with resolute efforts was
overcome. Subsequently, MRSA was made a notifiable diagnosis in Sweden in 2000.
Methods: From the start of being a notifiable disease in January 2000, the Swedish Institute for
Infectious Disease Control (SMI) initiated an active surveillance of MRSA.
Results: The number of reported MRSA-cases in Sweden increased from 325 cases in 2000 to 544
in 2003, corresponding to an overall increase in incidence from 3.7 to 6.1 per 100000 inhabitants.
Twenty five per cent of the cases were infected abroad. The domestic cases were predominantly
found through cultures taken on clinical indication and the cases infected abroad through screening.
There were considerable regional differences in MRSA-incidence and age-distribution of cases.
Conclusion: The MRSA incidence in Sweden increased over the years 2000–2003. Sweden now
poises on the rim of the same development that was seen in the United Kingdom some ten years
ago. A quarter of the cases were infected abroad, reflecting that international transmission is now
increasingly important in a low-endemic setting. To remain in this favourable situation, stepped up
measures will be needed, to identify imported cases, to control domestic outbreaks and to prevent
transmission within the health-care sector.
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Background
Since its discovery in 1961, the occurrence of methicillin-
resistant  Staphylococcus  aureus (MRSA) has gradually
become more frequent over the world [1-3]. In the early
1990s, United Kingdom, the Netherlands and the Nordic
countries were essentially non-endemic for MRSA. Since
then, MRSA has become established as a common noso-
comial pathogen in the British health-care system [4,5].
The Netherlands and the Nordic countries still have
favourable MRSA-situations, but are now observing stead-
ily increasing numbers of new cases reported [6-9]. Dur-
ing the late 1990s, Sweden experienced a large health-care
associated outbreak in the Västra Götaland County, which
with resolute efforts were overcome [10,11]. Subse-
quently, MRSA carriage and disease was made notifiable
from January 1, 2000, according to the Swedish Commu-
nicable Disease Act.
The aim of the present study was to investigate the epide-
miology in a low- or non-endemic situation, as is still the
case in Sweden, which in turn may reveal basic mecha-
nisms for MRSA spread that may not be perceived in coun-
tries where MRSA is more or less ubiquitous.
Methods
Under the Communicable Disease Act, both the micro-
biological laboratory having diagnosed MRSA and the cli-
nician having seen the patient with the pathogen are
obliged to report all new cases of either colonisation or
infection with MRSA to the County Medical Officer for
Communicable Disease Control and to the Swedish Insti-
tute for Infectious Disease Control (SMI). At the SMI, the
notifications from the two sources are merged into case
records, using a unique personal identification number
issued to all residents in Sweden, and used in all health
care contacts. From the start of MRSA being notifiable in
January 2000, the SMI had in place an active surveillance
system feeding detailed information on all cases of MRSA
into a national database. The SMI actively completed and
validated the epidemiological information on each noti-
fied case, through the courtesy of specially appointed con-
tact persons in each county, with data compiled after the
epidemiological investigation around the case was com-
pleted. Cases were found through cultures taken on clini-
cal indication as well as through screening and contact
tracing. Each county has its own rules regarding screening
and contact tracing practices, these practices are however
in reality similar. Sites cultured include vestibulum nasi,
perineum, breakages in the skin barrier, such as wounds,
eczemas, etc., and urinary catheters. The oropharynx is
also commonly cultured for screening and contact tracing
purposes. Patients having received health care outside of
Sweden, or within Sweden in areas where MRSA preva-
lence is known to be high, are screened for MRSA in all
counties. In this study we used surveillance data from Jan-
uary 2000 to December 2003. Isolates from all new cases
were sent to the SMI and the laboratory diagnosis of
MRSA was confirmed with polymerase chain reaction
(PCR) for the mecA and the nuc genes [12]. Demographic
data were obtained from the official statistics published
by Statistics Sweden (SCB) [13]. Through a questionnaire
to all 29 clinical microbiology laboratories in Sweden,
denominator data on the number of individuals with cul-
tures positive for Staphylococcus aureus were requested by
the SMI.
Within the present study a case of MRSA was defined as a
case of either colonisation or infection with MRSA. When
a case is said to be "infected" with MRSA, this refers to the
transmission of MRSA to this person, with resulting colo-
nisation or infection. The MRSA incidence was defined as
the number of new cases, during a specified year and in a
specified geographic area, divided by the population
number of the same area in the same year and expressed
as number of cases per 100000 inhabitants. The MRSA
proportion was defined as the number of new cases, dur-
ing a specified year and in a specified geographic area,
divided by all cases with a laboratory diagnosis of Staphy-
lococcus aureus, expressed as a percentage.
Map of Sweden showing county boundaries and the three big  city counties: Skåne, Stockholm and Västra Götaland Figure 1
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Sweden is divided in 21 counties. Three of these, Stock-
holm County, Västra Götaland County and Skåne
County, have considerably more inhabitants than the rest,
1.8, 1.5 and 1.1 million inhabitants, respectively, and also
include the three biggest cities, Stockholm, Göteborg, and
Malmö (Figure 1). The other counties have between
57000 and 414000 inhabitants (average of 247000).
Since the three most populous counties comprised 71% of
the MRSA cases, but only 50% of the total Swedish popu-
lation, they were studied separately. The other 18 counties
had considerably lower MRSA-incidence, sometimes with
just a very small number or no cases at all in single years,
and were for that reason analysed together.
Correlation analysis was performed in Stata 8.2 [14].
Results
The number of reported MRSA cases in Sweden increased
from 325 cases in 2000 to 423 in 2001, 441 in 2002 and
544 in 2003. A total of 1,733 cases were thus reported dur-
ing the entire study period, 1,240 infected in Sweden
(domestic cases) and 443 infected abroad. As shown in
Figure 2 these numbers corresponded to an overall
increase in incidence from 3.7 to 6.1 per 100,000 inhabit-
ants. The total increase was due to a combined increase in
domestic cases (from 2.5 to 4.4 per 100,000) and in cases
infected abroad (from 0.92 to 1.6 per 100,000). The pro-
portion of cases infected abroad was constantly near 25%
of all reported cases, for the whole of the country.
The Skåne County and the Stockholm County contributed
most to the overall increase in MRSA during the period
(Figure 2). Contrary to this, the incidence of domestic
cases in the Västra Götaland County was higher in 2000
than later during the study period, reflecting the after-
maths of the large outbreak in that county peaking in
1998 [10,11]. In the three large counties, changes in the
number of cases infected domestically and abroad paral-
leled each other. In the smaller counties a steadily increas-
ing incidence of cases from abroad was seen. In
Stockholm the increase in domestic incidence was so pro-
nounced, compared to the increase in cases infected
abroad, that the proportion of cases infected abroad
decreased from 28% in 2000 to 17.5% in 2003.
Cultures positive for MRSA were obtained: 1) on clinical
indications (e.g. symptomatic patients), 2) as screening
samples from patients belonging to a risk-group (e.g.
patients having received health-care abroad), or 3) as part
of the contact-tracing in the investigation around an
already identified case. The domestic cases were predomi-
nantly found through cultures on clinical indications
(58%), with contact tracing as the second most common
indication (35%), and screening on the third place (5%);
in the remaining 1% the reason for culture was unknown.
The patients infected abroad were mostly found through
screening (53%), followed by clinical indication (39%)
and contact tracing (8%).
Figure 3 shows that the incidence of MRSA cases discov-
ered by cultures taken on clinical indication varied around
two cases per 100000 inhabitants, without a clear trend
over time, for all parts of the country apart from the Stock-
holm County, where the incidence of clinical cases rose
year by year from 3.5, in 2000, to 8.0 cases per 100000
inhabitants in 2003. The Skåne County had the largest
proportion of cases found through either contact tracing
or screening (range 52% to 70%), compared to the Västra
Götaland County (range 35% to 62%), the Stockholm
County (range 24% to 42%) and the smaller counties
(range 41% to 47%).
Figure 4 shows a scatter plot of the proportion of MRSA-
cases out of all cases diagnosed with S. aureus against inci-
dence of MRSA (MRSA cases per 100,000 inhabitants) for
each of the Swedish counties and each of the years 2000 –
2003. The two measures were highly correlated to each
other – Spearman correlation coefficients (rSpearman) 0.98,
0.99, 0.92 and 0.90, respectively for each of the years
2000–2003 (p < 0.0001 for all of the years).
The age distribution of cases showed marked differences
between counties, as seen in Figure 5. Stockholm, Västra
Götaland and the smaller counties had their highest inci-
dence in the age-group above 80 years of age, with 61, 10
and 8.0 cases per 100,000 inhabitants respectively. Skåne
on the other hand had the highest age related incidence in
Incidence (cases per 100000 inhabitants) of MRSA cases,  infected in Sweden (■ ), abroad ( ) and unknown where  infected (), notified in Sweden in total, in each of the coun- ties Skåne, Stockholm, Västra Götaland and the other 18  counties presented together, for the years 2000–2003 Figure 2
Incidence (cases per 100000 inhabitants) of MRSA cases, 
infected in Sweden (■ ), abroad ( ) and unknown where 
infected (), notified in Sweden in total, in each of the coun-
ties Skåne, Stockholm, Västra Götaland and the other 18 
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the 0–9 years group, with 15 cases per 100,000 inhabit-
ants, and in the ages above 80 years the incidence was 10
cases per 100,000 inhabitants. Overall, MRSA incidence
was lowest in the ages 10–19 years.
The average incidence of MRSA acquired abroad, over the
period 2000 – 2003, was highest in the age group 0–9
years (1.8 cases per 100,000 inhabitants and year) and in
the age group 20–29 years (1.9 cases per 100,000 inhabit-
ants and year), in Sweden in total. The average incidence
of domestically infected cases increased markedly with
age, from 2.1 cases per 100,000 inhabitants in the age
group 40–49 years to 16.5 cases per 100,000 inhabitants
in the age group above 80 years, while the incidence of
cases infected abroad decreased with age.
Discussion
This study shows a year-by-year increasing incidence of
MRSA, in Sweden, since this pathogen became notifiable
in 2000. There were also notable regional differences
between counties both in total and age-specific incidence.
The three big city regions had higher incidences than the
rest of the country. The incidence in the Västra Götaland
County in 2000 represents the tail of a health-care related
outbreak in that county in the late 1990s. Since the begin-
ning of our study period in 2000, the Stockholm County
has experienced several simultaneous health-care associ-
ated outbreaks, which were reflected in the incidence of
10 domestic cases per 100,000 inhabitants. These out-
breaks could explain the high incidences in the oldest age
groups noted in the Stockholm County. The Skåne
County, the other big city region with an increasing inci-
dence during the study period, had a totally different age
profile for the MRSA-cases reported, reflecting fewer
health-care related outbreaks and a higher proportion of
community-acquired MRSA.
This is the first nation-wide study on the MRSA-situation
in Sweden, one of few countries with very low MRSA
endemicity. Finland and the Netherlands have recently
reported on their respective MRSA-epidemiology [7,8].
From Norway official surveillance statistics are available
[9]. The occurrence of MRSA is declared to be increasing
in all of these countries, but still on a lower level than
most other countries [15].
The present study was a population-based study starting
from a mandatory notification system. The Swedish statu-
tory notification system was recently assessed by Jansson
et al. [16]. It was concluded that it is a highly sensitive
reporting system, further improved by the double report-
ing of clinicians and laboratories. The overall sensitivity
was found to lie well above 90% for the studied diag-
noses.
MRSA was first observed as an increasing problem within
health care institutions. In recent years more and more
attention has been paid to MRSA outside health care, des-
ignated community-associated MRSA (CA-MRSA). Conse-
quently, most studies have focused either on spread of
MRSA as an infection control problem within hospitals
and other health care institutions, on the epidemiology of
CA-MRSA, or approached MRSA from a microbiological
point of view. However, to get a more complete picture of
MRSA-epidemiology such studies need to be comple-
mented by regional and national population based stud-
ies, approaching MRSA occurrence as a public health issue
in society as a whole.
A quarter of the Swedish MRSA-cases in 2000–2003 were
infected abroad, as shown in this study. These cases stand
out more distinctly against the low-endemic Swedish
MRSA-situation, than elsewhere. For the same reason
imported MRSA-cases are, with few exceptions [8,9],
rarely accounted for in studies and national statistics.
MRSA in low-endemic circumstances, however, constitute
opportunities to study international transmission of
MRSA. Even though the overall proportion of MRSA
acquired abroad was constant over time, this was the com-
bined result of two opposing trends. In the Stockholm
and the Skåne Counties increasing incidences due to
domestic outbreaks and community transmission with
fairly constant incidence of imported cases were noted,
while in the Västra Götaland Region (from 2001) and the
other counties, the incidence was increasing more in the
imported than in the domestic cases.
Incidence (cases per 100000 inhabitants) of different indica- tions for culture: clinical indication (■ ), screening ( ), con- tact tracing ( ) and unknown/other indication (), notified  in Sweden in total, each of the counties Skåne, Stockholm,  Västra Götaland and the other 18 counties presented  together for the years 2000–2003 Figure 3
Incidence (cases per 100000 inhabitants) of different indica-
tions for culture: clinical indication (■ ), screening ( ), con-
tact tracing ( ) and unknown/other indication (), notified 
in Sweden in total, each of the counties Skåne, Stockholm, 
Västra Götaland and the other 18 counties presented 
together for the years 2000–2003.BMC Infectious Diseases 2006, 6:30 http://www.biomedcentral.com/1471-2334/6/30
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Clinical indication was a common motive for the culture
that identified the MRSA-cases infected both domestically
(59%) and abroad (39%). It was, however, reassuring,
regarding the way the counties operate their MRSA situa-
tions, to see that the majority of cases infected abroad
were found through screening practices and as much as a
third of the domestically infected cases were found by
contact-tracing. There were no trends for these parameters
over the study period, in the country as a whole.
Regional differences within countries have been observed
by other authors [1,5,17-20]. Activity in screening, out-
break investigations and contact tracing regarding MRSA
may differ between regions and countries. Reporting of
numbers of MRSA-cases including cases first identified
through cultures taken for screening or outbreak-investi-
gation purposes may thus be subject to bias. For this rea-
son information was collected, and accounted for in this
study, on each case concerning the indication for the cul-
ture that first identified the individual as a MRSA-case. In
the present study the Skåne County was shown to have the
second highest total incidences of MRSA during the years
2001–2003. The majority of cases in Skåne (between 63
and 70 per cent) where, however, found through active
search for MRSA. This illustrates how misleading a com-
parison between regions can be if only total incidences
had been used. If the number of clinically found MRSA
cases is assumed to reflect the occurrence of MRSA more
truly, the Skåne County did not have a higher occurrence
of MRSA than the rest of Sweden.
The MRSA proportion has been described as a rough
measure of MRSA occurrence [18]. We had the opportu-
nity to correlate the MRSA proportion to incidence figures
based on census data. In the Swedish setting and during
the time period studied these two ways of measuring
MRSA occurrence correlated excellently.
The occurrence of MRSA is frequently measured as the
proportion of MRSA out of all S. aureus. One reason for
using this proportion is convenience. Any bacteriologic
laboratory can easily summate cultures positive for S.
aureus, and so get the denominator for the proportion.
Another reason for using this proportion may be that pop-
ulation denominators are difficult to estimate if the catch-
ment population of a laboratory is not clearly defined.
The validity and comparability of all measures of occur-
rence depend on the case definition and the case detection
practices used. However, the MRSA proportion is a rela-
tive measure of occurrence depending not only on the
amount of MRSA, but also on the total amount of S.
aureus. Circumstances could thus affect the proportion in
a less predictable way than ordinary population based
measures of incidence and prevalence.
We interpret our finding of high correlation between
MRSA proportion and MRSA incidence in this study as
basically a correlation between denominators – the total
number of cultures positive for S. aureus per county and
the population of the same county. The correlation sug-
gests that the overall culturing practices were similar
between Swedish counties, since the yield of S. aureus was
similar in relation to population. The finding shows that
in the Swedish setting, with low MRSA occurrence, and
during the period studied, these two ways of measuring
MRSA occurrence could be used interchangeably. How-
Average yearly incidence of MRSA per age group (cases per  100000 inhabitants in each of the ten-year age-groups from  0–9 years to 80 years and above) and county, in Sweden,  over the years 2000 to 2003 Figure 5
Average yearly incidence of MRSA per age group (cases per 
100000 inhabitants in each of the ten-year age-groups from 
0–9 years to 80 years and above) and county, in Sweden, 
over the years 2000 to 2003.
Scatter-plot and linear curve-fit of MRSA-proportion (per- centage of MRSA-cases out of all Staphylococcus aureus cases)  against MRSA-incidence (cases per 100000 inhabitants) for  the years 2000 (●  and  ; N = 19), 2001 (■  and ---; N = 16),  2002 (▲  and .....; N = 19) and 2003 ( and  ; N = 20) Figure 4
Scatter-plot and linear curve-fit of MRSA-proportion (per-
centage of MRSA-cases out of all Staphylococcus aureus cases) 
against MRSA-incidence (cases per 100000 inhabitants) for 
the years 2000 (●  and  ; N = 19), 2001 (■  and ---; N = 16), 
2002 (▲  and .....; N = 19) and 2003 ( and  ; N = 20). Each 
data point represents one county and one or several labora-
tories within this county.
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ever, the correlation in this study between MRSA propor-
tion and incidence should not be interpreted as evidence
that the proportion of MRSA out of all S. aureus is gener-
ally a valid estimate of MRSA occurrence in the popula-
tion.
Conclusion
This study has shown that the MRSA incidence in Sweden
increased over the years 2000–2003. Sweden now poises
on the rim of the same development that was seen in the
United Kingdom some ten years ago. A quarter of the
cases were infected abroad, reflecting that international
transmission is now increasingly important in a low-
endemic setting. To remain in the present favourable situ-
ation, stepped up measures will be needed, to identify
imported cases, to control domestic outbreaks and to pre-
vent transmission within the health-care sector. MRSA-
proportion and MRSA-incidence correlated excellently as
measures of MRSA-occurrence. Further and more detailed
studies of the domestic Swedish MRSA epidemiology are
needed as well as studies of the consequences of interna-
tional transmission of MRSA in low-endemic settings.
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